PHAT icon

Phathom Pharmaceuticals

84 hedge funds and large institutions have $820M invested in Phathom Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $843M → $820M (-$23.3M)

4% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 23

Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$523K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$13.5M
2 +$8.16M
3 +$7.09M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$5.03M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.95M

Top Sellers

1 -$1.96M
2 -$1.6M
3 -$1.42M
4
MWNA
Marshall Wace North America
New York
-$1.17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$187M
2
$100M
3
$66.4M
4
$64.1M
5
$62.5M
6
$58.2M
7
$38.5M
8
$38M
9
$37.6M
10
$19.3M
11
$17.7M
12
$13.5M
13
$11.4M
14
$10.6M
15
$9.11M
16
$7.22M
17
$7.09M
18
$5.98M
19
$5.97M
20
$5.5M
21
$5.42M
22
$4.95M
23
$3.88M
24
$3.35M
25
$3.2M